Pyxis Oncology【PYXS】株式ニュース

名称	銘柄コード	市場	種別
Pyxis Oncology Inc	PYXS	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	4.34	20:00:11

始値	安値	高値	終値	前日終値
				4.34

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/09	20:30	GLOBE	Pyxis Oncology to Present at the RBC Capital Markets Global..
2024/3/29	05:30	GLOBE	Pyxis Oncology Reports Inducement Grants Under Nasdaq..
2024/3/27	20:30	GLOBE	Pyxis Oncology Obtains $8 Million Payment for the Sale of..
2024/3/21	20:30	GLOBE	Pyxis Oncology Provides Corporate Update and Reports..
2024/3/13	21:00	GLOBE	Pyxis Oncology Expands Board of Directors with Appointment..
2024/3/09	06:03	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/3/08	06:30	GLOBE	Pyxis Oncology to Present at Leerink Global Biopharma..
2024/3/06	06:45	GLOBE	Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102..
2024/2/28	21:02	EDGAR2	Form 8-K - Current report
2024/2/27	22:00	GLOBE	Pyxis Oncology Announces $50 Million Private Placement
2023/12/30	06:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/30	06:30	GLOBE	Pyxis Oncology Reports Inducement Grants Under Nasdaq..
2023/12/07	06:50	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/12/01	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/28	21:22	EDGAR2	Form 8-K - Current report
2023/11/28	21:00	GLOBE	Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D.,..
2023/11/18	06:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/08	06:46	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08	06:44	EDGAR2	Form 8-K - Current report
2023/11/08	06:30	GLOBE	Pyxis Oncology Announces Initiatives to Prioritize Lead ADC..
2023/10/28	05:34	EDGAR2	Form 8-K/A - Current report: [Amend]
2023/9/29	05:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/28	07:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/28	07:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/27	22:18	GLOBE	Pyxis Oncology Announces Four Abstracts Accepted for Poster..
2023/9/26	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/26	06:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/23	08:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/23	08:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/09	06:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/09	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/06	06:08	EDGAR2	Form 144 - Report of proposed sale of securities
2023/9/01	05:01	GLOBE	Pyxis Oncology to Participate in Two Upcoming Investment..
2023/8/25	13:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/8/24	06:30	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
2023/8/24	06:28	EDGAR2	Form POS AM - Post-Effective amendments for registration..
2023/8/24	06:28	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2023/8/23	21:47	EDGAR2	Form 8-K - Current report
2023/8/23	21:35	GLOBE	Pyxis Oncology Successfully Completes Acquisition of..
2023/8/12	06:00	EDGAR2	Form 144 - Report of proposed sale of securities
2023/8/11	20:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/11	20:26	EDGAR2	Form 425 - Prospectuses and communications, business..
2023/8/11	20:25	EDGAR2	Form 8-K - Current report
2023/8/11	20:00	GLOBE	Pyxis Oncology Reports Financial Results for Second-Quarter..
2023/8/11	19:35	EDGAR2	Form 425 - Prospectuses and communications, business..
2023/8/11	19:34	EDGAR2	Form 8-K - Current report
2023/8/02	06:14	EDGAR2	Form 144 - Report of proposed sale of securities
2023/8/02	05:01	GLOBE	Pyxis Oncology to Present at BTIG Virtual Biotechnology..
2023/8/01	05:41	EDGAR2	Form 144 - Report of proposed sale of securities
2023/7/28	06:02	EDGAR2	Form 144 - Report of proposed sale of securities